Other Non-Current Liabilities
Gilead Sciences Other Non-Current Liabilities decreased by 1.4% to $1.17B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 10.0%, from $1.30B to $1.17B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -25.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
Significant changes may reflect shifts in lease accounting, changes in employee benefit plans, or the emergence of long-term legal risks.
Detailed definition
A catch-all category for long-term obligations that do not fall into major classifications like debt or deferred taxes....
Peer comparison
Varies significantly by industry; companies with large physical retail footprints often show higher values here due to long-term leases.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.18B | $962.00M | $976.00M | $944.00M | $988.00M | $1.11B | $1.18B | $1.28B | $1.35B | $924.00M | $1.28B | $1.40B | $1.42B | $1.40B | $1.30B | $1.34B | $1.29B | $1.18B | $1.17B |
| QoQ Change | — | -18.2% | +1.5% | -3.3% | +4.7% | +11.9% | +6.6% | +8.3% | +6.0% | -31.8% | +38.5% | +9.0% | +1.6% | -1.6% | -7.2% | +3.2% | -3.5% | -8.4% | -1.4% |
| YoY Change | — | — | — | — | -16.0% | +15.0% | +20.8% | +35.3% | +37.0% | -16.5% | +8.6% | +9.2% | +4.7% | +51.1% | +1.2% | -4.2% | -9.0% | -15.3% | -10.0% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's other non-current liabilities?
- Gilead Sciences (GILD) reported other non-current liabilities of $1.17B in Q4 2025.
- How has Gilead Sciences's other non-current liabilities changed year-over-year?
- Gilead Sciences's other non-current liabilities decreased by 10.0% year-over-year, from $1.30B to $1.17B.
- What is the long-term trend for Gilead Sciences's other non-current liabilities?
- Over 5 years (2020 to 2025), Gilead Sciences's other non-current liabilities has grown at a -25.7% compound annual growth rate (CAGR), from $5.13B to $1.17B.
- What does other non-current liabilities mean?
- Miscellaneous long-term debts and obligations that aren't due for at least a year.